Rebecca I Johnson (Rebecca Johnson)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Top Venues

Nature structural & molecular biology

Nature communications

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew R Chang, Luke Tomasovic, Natalia A Kuzmina, Adam J Ronk, Patrick O Byrne, Rebecca I Johnson, Nadia Storm, Eduardo Olmedillas, Yixuan J Hou, Alexandra Schaefer, Sarah R Leist, Longping V Tse, Hanzhong Ke, Christian Coherd, Katrina Nguyen, Maliwan Kamkaew, Anna N Honko, Quan Zhu, Galit Alter, Erica Ollmann Saphire, Jason S Mclellan, Anthony Griffths, Ralph S Baric, Alexander Bukreyev, Wayne A Marasco
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern. Nature communications 13 (1) (2022)
Pavel A Nikitin, Jillian M DiMuzio, John P Dowling, Nirja B Patel, Jamie L Bingaman-Steele, Baron C Heimbach, Noeleya Henriquez, Chris Nicolescu, Antonio Polley, Eden L Sikorski, Raymond J Howanski, Mitchell Nath, Halley Shukla, Suzanne M Scheaffer, James P Finn, Li-Fang Liang, Todd Smith, Nadia Storm, Lindsay G A McKay, Rebecca I Johnson, Lauren E Malsick, Anna N Honko, Anthony Griffths, Michael S. Diamond, Purnanand Sarma, Dennis H Geising, Michael J Morin, Matthew K Robinson
IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2. Science immunology 7 (75) (2022)
Tianshu Xiao, Jianming Lu, Jun Zhang, Rebecca I Johnson, Lindsay G A McKay, Nadia Storm, Christy L Lavine, Hanqin Peng, Yongfei Cai, Sophia Rits-Volloch, Shen Lu, Brian D Quinlan, Michael Farzan, Michael S Seaman, Anthony Griffiths, Bing Chen
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent. Nature structural & molecular biology 28 (2) (2021)